|
Multimedia
Images, audio, and video related to cancer research
Calendar
Meetings, seminars, and press conferences focused on cancer research
Resources
Information on cancer types, treatment, prevention, and more
 Sponsored by:
The Cancer News Portal is supported by the National Cancer Institute of the National Institutes of Health. Additional information on cancer research, prevention, and treatment is available at www.cancer.gov |
Breaking News
Key: Meeting
Showing releases 1026-1050 out of 1212. << < 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 > >>
Public Release: 5-Mar-2013
 Nature Reviews GeneticsMolecular coordination in evolution: A review in 'Nature Reviews Genetics' Spanish National Cancer Research Centre researchers Alfonso Valencia, Director of the Structural Biology and Biocomputing Programme and David de Juan, jointly with Florencio Pazos, from the Spanish National Centre for Biotechnology, publish a review on the latest computational methods that, based on evolutionary principles, are revolutionizing the field of analysis and prediction of protein structure, function and protein-protein interactions, as well as the short- and long-term expectations for the field. Contact: Nuria Noriega
Public Release: 4-Mar-2013
Proceedings of the National Academy of SciencesDiscovery opens door to new drug options for serious diseases Researchers have discovered how oxidative stress can turn to the dark side a cellular protein that's usually benign, and make it become a powerful, unwanted accomplice in neuronal death. This finding could ultimately lead to new therapeutic approaches to many of the world's debilitating or fatal diseases. 
National Institutes of Health
Contact: Joseph Beckman
Public Release: 4-Mar-2013
Annals of Internal MedicineColon cancer screening doubles with new e-health record use Researchers used electronic health records to identify Group Health patients who weren't screened regularly for cancer of the colon and rectum -- and to encourage them to be screened. This centralized, automated approach doubled these patients' rates of on-time screening -- and saved health costs -- over two years. The Mar. 5 Annals of Internal Medicine published the randomized controlled trial.
NIH/National Cancer Institute
Contact: Rebecca Hughes
Public Release: 4-Mar-2013
Annals of Internal MedicineAnnals of Internal Medicine tip sheet for March 5, 2013 Below is information about articles being published in the March 5 issue of Annals of Internal Medicine. Contact: Megan Hanks
Public Release: 4-Mar-2013
LancetNew data show countries around the world grappling with changing health challenges Alzheimer's disease is the fastest growing threat to health in the US. HIV/AIDS and alcohol are severely eroding the health of Russians. Violence is claiming the lives of young men in large swaths of Latin America. Despite health gains in sub-Saharan Africa, infectious diseases still cause hundreds of thousands of child deaths. These findings will be announced on March 5 at the Bill & Melinda Gates Foundation in Seattle, by IHME Director Dr. Christopher Murray and Bill Gates.
Bill & Melinda Gates Foundation
Contact: Rhonda Stewart
Public Release: 4-Mar-2013
PLOS ONEThe right dose for oncology EPFL researchers develop a tool for oncologists using the electrical signature of cancer cells to get just the right treatment dosage for each patient. Contact: Lionel Pousaz
Public Release: 4-Mar-2013
Health & PlaceNeighborhood poverty and health insurance figure in late-stage diagnosis of breast cancer A team of scientists was assembled by the North American Association of Central Cancer Registries to examine breast cancer stage at diagnosis among 161,619 women aged 40 years and older diagnosed in ten participating US states. The team's findings are reported in the current issue of the journal Health & Place.
Komen for the Cure and North American Association of Central Cancer Registries
Contact: Betsy A. Kohler
Public Release: 4-Mar-2013
Scientific ReportsStudy uncovers enzyme's double life, critical role in cancer blood supply Studied for decades for their essential role in making proteins within cells, several amino acids known as tRNA synthetases were recently found to have an unexpected -- and critical -- additional role in cancer metastasis. University of Vermont researchers determined that threonyl tRNA synthetase leads a "double life," regulating a pathway used by invasive cancers to induce the formation of new blood vessels, and a new food supply to sustain their growth.
National Institutes of Health
Contact: Jennifer Nachbur
Public Release: 4-Mar-2013
Proceedings of the National Academy of SciencesDiscovery of 'executioner' protein opens door to new options for stroke ALS, spinal cord injury Oxidative stress turns a protein that normally protects healthy cells into their executioner, according to a study released today in the Proceedings of the National Academy of Sciences journal.
National Institutes of Health, Burke Medical Research Institute, ALS Association
Contact: Wendy Sarubbi
Public Release: 4-Mar-2013
Nature GeneticsFirst evidence that obesity gene is risk factor for melanoma The gene most strongly linked to obesity and over eating may also increase the risk of malignant melanoma -- the most deadly skin cancer, according to Cancer Research UK scientists at the University of Leeds.
Cancer Research UK
Contact: Rachel Barson
Public Release: 4-Mar-2013
Journal of Clinical OncologyProspective study finds many children with retinoblastoma can safely forego adjuvant chemotherapy The summary of a study being published online Mar. 4, 2013 in the Journal of Clinical Oncology reports that in certain children with retinoblastoma, adjuvant chemotherapy can be avoided without risking worsening the disease or relapsing. Contact: Nicole Racadag
Public Release: 3-Mar-2013
Nature MedicineCancer vaccines self-sabotage, channel immune attack to injection site UT MD Anderson scientists have found that many therapeutic cancer vaccines fail because they attract more T cells to the injection site than to the tumors. Replacing the adjuvant IFA with a saline solution reversed that, destroying tumors and minimizing injection site reaction.
NIH/National Cancer Institute, Melanoma Research Alliance
Contact: Scott Merville
Public Release: 3-Mar-2013
Nature ImmunologyResearchers discover how to shutdown cancer's powerful master protein The powerful master regulatory transcription factor called Bcl6 is key to the survival of a majority of aggressive lymphomas, which arise from the B-cells of the immune system. The protein has long been considered too complex to target with a drug since it is also crucial to the healthy functioning of many immune cells in the body, not just B cells gone bad.
NIH/National Cancer Institute, Burroughs Wellcome Foundation, Chemotherapy Foundation
Contact: Lauren Woods
Public Release: 3-Mar-2013
Nature BiotechnologyInternational consortium builds 'Google Map' of human metabolism Building on earlier pioneering work by researchers at the University of California, San Diego, an international consortium of university researchers has produced the most comprehensive virtual reconstruction of human metabolism to date. Scientists could use the model, known as Recon 2, to identify causes of and new treatments for diseases like cancer, diabetes and even psychiatric and neurodegenerative disorders. Contact: Catherine Hockmuth
Public Release: 3-Mar-2013
Nature ImmunologyGene discovery reveals importance of eating your greens Eating your greens may be even more important that previously thought, with the discovery that an immune cell population essential for intestinal health could be controlled by leafy greens in your diet. The immune cells, named innate lymphoid cells, are found in the lining of the digestive system and protect the body from 'bad' bacteria in the intestine. They are also believed to play an important role in controlling food allergies, inflammatory diseases and obesity, and may even prevent the development of bowel cancers.
National Health and Medical Research Council, Sylvia and Charles Viertel Foundation, Howard Hughes Medical Institute, Victorian Government
Contact: Liz Williams
Public Release: 1-Mar-2013
Journal of Clinical InvestigationTumors deliberately create conditions that inhibit body's best immune response New research in the Journal of Clinical Investigation reveals that tumors in melanoma patients deliberately create conditions that knock out the body's 'premier' immune defense and instead attract a weaker immune response unable to kill off the tumor's cancerous cells. Contact: Marianne Slegers
Public Release: 1-Mar-2013
Journal of Clinical InvestigationJCI early table of contents for Mar. 1, 2013 The following release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Mar. 1, 2013, in the JCI: Coordinating adaptive responses to cardiac stress; A nanogel-based therapy for the treatment of lupus; and many more. Contact: Jillian Hurst
Public Release: 1-Mar-2013
Cancer'Where you're treated matters' in terms of cancer survival A study of older patients with advanced head and neck cancers has found that where they were treated significantly influenced their survival.
National Institutes of Health
Contact: Dean Forbes
Public Release: 1-Mar-2013
Journal of Adolescent HealthCancer doesn't change young girls' desire to have children, Moffitt Cancer Center study shows Researchers at Moffitt Cancer Center and colleagues have found that healthy adolescent females have predetermined expectations for becoming parents in the future, but have concerns about fertility and childbearing should they develop a life-threatening illness, such as cancer. Contact: Kim Polacek
Public Release: 1-Mar-2013
Journal of ImmunologyMechanisms regulating inflammation associated with type 2 diabetes, cancer identified A study led by researchers at Boston University School of Medicine has identified epigenetic mechanisms that connect a variety of diseases associated with inflammation.
NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Contact: Jenny Eriksen Leary
Public Release: 1-Mar-2013
Gastrointestinal EndoscopyStudy confirms safety of colonoscopy Colon Cancer Awareness Month is about encouraging more people to get tested for colorectal cancer. Colonoscopy is the most reliable screening test. A current study from the German Cancer Research Center confirms that, contrary to what some critics say, it is also safe. If more people made use of screening tests, about half of all new colorectal cancer cases and deaths from this cancer could be avoided in Germany every year. Contact: Sibylle Kohlstädt
Public Release: 1-Mar-2013
Nature Chemical BiologyNew chemical probe provides tool to investigate role of malignant brain tumor domains UNC researchers announce the discovery of a chemical probe that can be used to investigate the L3MBTL3 methyl-lysine reader domain. The probe, named UNC1215, will provide researchers with a powerful tool to investigate the function of malignant brain tumor domain proteins in biology and disease.
National Institutes of Health, University Cancer Research Fund
Contact: William Davis
Public Release: 28-Feb-2013
Particle & Particle Systems CharacterizationTrackable drug-filled nanoparticles -- a potential weapon against cancer Tiny particles filled with a drug could be a new tool for treating cancer in the future. A new study published by Swedish scientists in Particle & Particle Systems Characterization shows how such nanoparticles can be combined to secure the effective delivery of cancer drugs to tumor cells -- and how they can be given properties to make them visible in MR scanners and thus be rendered trackable.
The Swedish Research Council and others.
Contact: Press Office
Public Release: 28-Feb-2013
Journal of the National Cancer InstituteNearly 1 in 4 women newly diagnosed with breast cancer A study by researchers found that nearly one in four women (23 percent) newly diagnosed with breast cancer reported symptoms consistent with post-traumatic stress disorder shortly after diagnosis, with increased risk among black and Asian women.
NIH/National Cancer Institute, US Department of Defense
Contact: Stephanie Berger
Public Release: 28-Feb-2013
Cancer CellGroundbreaking UK study shows key enzyme missing from aggressive form of breast cancer A groundbreaking new study led by the University of Kentucky Markey Cancer Center's Dr. Peter Zhou found that triple-negative breast cancer cells are missing a key enzyme that other cancer cells contain -- providing insight into potential therapeutic targets to treat the aggressive cancer. Zhou's study is unique in that his lab is the only one in the country to specifically study the metabolic process of triple-negative breast cancer cells. Contact: Allison Perry
Showing releases 1026-1050 out of 1212. << < 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 > >>
|
Search News Releases
|
|||||||||||||||||||||||||
Journal 
 |
||||
|
|
 |
|